Medicamen Biotech Limited Market Cap ($38.45 Million)
Market Cap & Net Worth: Medicamen Biotech Limited (MEDICAMEQ)
Medicamen Biotech Limited market cap. Medicamen Biotech Limited (NSE:MEDICAMEQ) has a market capitalization of $38.45 Million (Rs3.56 Billion) as of November 5, 2026. Listed on the NSE stock exchange, this India-based company holds position #22659 globally and #1246 in its home market, demonstrating a -0.32% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Medicamen Biotech Limited's stock price Rs262.15 by its total outstanding shares 13562815 (13.56 Million). Also see Medicamen Biotech Limited (MEDICAMEQ) cash conversion ratio for how efficiently the company converts equity into cash flow.
Medicamen Biotech Limited Market Cap History (2021–2026)
Medicamen Biotech Limited market cap history from 2021 to 2026. Data shows change from $129.59 Million to $38.45 Million (-13.70% CAGR). Check Medicamen Biotech Limited stock quote for real-time trading data and today's change.
Medicamen Biotech Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Medicamen Biotech Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Medicamen Biotech Limited annual equity growth to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.02x
Medicamen Biotech Limited's market cap is 0.02 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.40x
Medicamen Biotech Limited's market cap is 0.40 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $129.59 Million | $1.13 Billion | $121.29 Million | 0.11x | 1.07x |
| 2022 | $121.37 Million | $1.15 Billion | $148.98 Million | 0.11x | 0.81x |
| 2023 | $88.28 Million | $1.41 Billion | $148.44 Million | 0.06x | 0.59x |
| 2024 | $75.16 Million | $1.79 Billion | $109.31 Million | 0.04x | 0.69x |
| 2025 | $53.49 Million | $1.63 Billion | $71.08 Million | 0.03x | 0.75x |
| 2026 | $38.45 Million | $1.98 Billion | $96.41 Million | 0.02x | 0.40x |
Competitor Companies of MEDICAMEQ by Market Capitalization
Companies near Medicamen Biotech Limited in the global market cap rankings as of November 5, 2026. Also see MEDICAMEQ total asset value for a full breakdown of the balance sheet.
Key companies related to Medicamen Biotech Limited by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #509 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #534 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #580 globally with a market cap of $46.03 Billion USD ( CN¥314.55 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #618 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #509 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #534 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $45.90 |
| #580 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $46.03 Billion | CN¥49.31 |
| #618 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.50 |
Market Capitalization of Medicamen Biotech Limited (2021–2026)
Market capitalization of Medicamen Biotech Limited from 2021 to today. Between 2021 and today, Medicamen Biotech Limited's market cap moved from $129.59 Million to $ 38.45 Million, with a yearly change of -13.70%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rs38.45 Million | -28.11% |
| 2025 | Rs53.49 Million | -28.84% |
| 2024 | Rs75.16 Million | -14.85% |
| 2023 | Rs88.28 Million | -27.27% |
| 2022 | Rs121.37 Million | -6.34% |
| 2021 | Rs129.59 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Medicamen Biotech Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $38.45 Million USD |
| MoneyControl | $38.45 Million USD |
| MarketWatch | $38.45 Million USD |
| marketcap.company | $38.45 Million USD |
| Reuters | $38.45 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Medicamen Biotech Limited
Medicamen Biotech Limited, a pharmaceutical company, research, develops, manufactures, markets, and sells pharmaceutical formulations in India and internationally. The company provides tablets, capsules, dry syrups, oral liquids, ointments, and other pharmaceutical dosage forms. Its products are used in therapeutic areas comprising cancer care, cardiology, CNS, diabetology, anti-infective, anti-m… Read more